Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Lexaria Bioscience (LEXX)

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications

biotech investing
Lexaria Bioscience (LEXX)

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended

biotech investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Amends Preferred Investment Options

pharmaceutical investing
Lexaria Bioscience (LEXX)

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Bioscience:  Drug Delivery Platform Innovator with Multiple Mainstream Applications

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales

biotech investing
Emyria Limited (EMD:AU)

Emyria Launches Global Services Platform Targeting International Drug Sponsors

psychedelics investing
Seegnal (SEGN:CA)

Seegnal Inc. Receives Gold Mark from the Standards Institution of Israel, Advancing Commercialization Readiness

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

biotech investing
Lexaria Bioscience (LEXX)

Lexaria's New Animal Study Aims to Expand Valuable Intellectual Property

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing
Lexaria Bioscience (LEXX)

Lexaria Applauds Eli Lilly's Foundayo Drug Approval

biotech investing
Seegnal (SEGN:CC)

Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program

pharmaceutical investing

Amplia Therapeutics Reports Four Additional Complete Responses and Improved Overall Survival Data in Accent Pancreatic Cancer Trial

Solvonis Therapeutics (None)

SVN-114 selected as the lead candidate for PTSD discovery programme

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Provides Update on Pharmaceutical Development Programs - Advancing Lead Drug Candidates Towards IND and Clinical Trial

pharmaceutical investing
InMed Pharmaceuticals (INM)

InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline

pharmaceutical investing
Cardiol Therapeutics (CRDL:CC)

Cardiol Therapeutics to Present at TD Cowen 46th Annual Health Care Conference

biotech investing

Latest News

More News

Outlook Reports world

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES